Stem cell transplantation, especially treatment with bone marrow mesenchymal stem cells (BMSCs), has been considered a promising therapy for the locomotor and neurological recovery of spinal cord injury (SCI) patients. However, the clinical benefits of BMSCs transplantation remain limited because of the considerably low viability and inhibitory microenvironment. In our research, low-intensity pulsed ultrasound (LIPUS), which has been widely applied to clinical applications and fundamental research, was employed to improve the properties of BMSCs. The most suitable intensity of LIPUS stimulation was determined. Furthermore, the optimized BMSCs were transplanted into the epicenter of injured spinal cord in rats, which were randomized 
| INTRODUC TI ON
Spinal cord injury (SCI) is broadly acknowledged as a crucial issue in clinical and experimental research due to its sudden yet unforeseeable nature and the extremely limited regenerative capability of the injured spinal cord, which could cause considerable losses to both individuals and the society. Recent estimates have stated that the annual incidence of SCI is around 17 000 new SCI cases in the United States. 1 In a global context, the incidence of SCI in 2007 was estimated to be 23 cases per million population or 179 312 cases per annum. 2 The pathology of SCI can be characterized by two phases of lesions: the primary lesion involves mechanical damage of the spinal cord relevant to hemorrhage, electrolyte flow and the release of lysosomes and other cellular components. The secondary lesion includes edema, ischemia, inflammation reactions, ionic imbalance (eg, intracellular calcium), excitotoxicity, caspase and calpain activation, neurotransmitter accumulation, and apoptosis. 3, 4 The subacute stage of SCI is known to be deleterious for axonal regeneration and functional recovery. This indicates that spontaneous recovery occurs in a limited time window. To date, no current treatments can substantially address the issues associated with injured spinal cords.
Stem cell-based therapy, especially BMSCs, has yielded encouraging results. [5] [6] [7] [8] BMSCs transplantation therapy is promising in mitigating the extent of SCI, not only due to a favorable ethical profile and safety, but also due to providing beneficial effects on various postinjury aspects: inflammation, apoptosis, axonal regrowth, angiogenesis, tissue sparing, astroglial scar, and motor recovery. [9] [10] [11] [12] It is well known that BMSCs secrete a large variety of molecules and many studies have shown beneficial impacts from these factors such as brain-derived neurotrophic factor (BDNF), nerve growth factor (NGF), vascular endothelial growth factor (VEGF), insulin-like growth factor (IGF), epidermal growth factor (EGF), and more.
13-19
Previously, neurotrophin and physical stimulation were commonly employed to enhance the effect of BMSCs. Specifically, low-intensity pulsed ultrasound (LIPUS), as a physical stimulation, appeared to be an effective assistant method. Over the past few decades, the medical use of ultrasound has been extended beyond imaging and diagnosis toward therapeutic applications. LIPUS exposure has been shown to increase proliferation in BMSCs. 20, 21 Studies of Lv et al showed that LIPUS and induced pluripotent stem cells-derived neural crest stem cells (iPSCs-NCSCs) could promote the regeneration and reconstruction of rat transected sciatic nerve, and LIPUS could enhance the viability and proliferation of iPSCsNCSCs. 22 Tsuang et al demonstrated that intervention with low-intensity pulsed ultrasound could promote Schwann cell proliferation and prevent cell death. 23 In this study, we investigate how LIPUS affect BMSCs in vitro and then transplant the optimized BMSCs to treat rats with SCI.
| MATERIAL S AND ME THODS

| Animals and ethics statement
Ten adult Wistar rats (female, 100-120 g) were prepared for BMSCs extraction, and another 40 adult Wistar rats (female, 250 ± 10 g)
were obtained for in vivo experiments. These rats all came from the Radiation Study Institute-Animal Center, Tianjin, People's Republic of China. The rats were provided with water and food freely, and were kept on a 12 hours light/dark cycle in a humidity and temperature-controlled animal facility. All the animal experimental procedures were executed according to the National Guidelines for 
| Isolation and culture of BMSCs
Female Wistar rats, weighing around 100-120 g, were sacrificed by cervical vertebra luxation after being anesthetized. Rat BMSCs were isolated from the bone marrow of bilateral tibial and femoral bones, then purified and passaged by attachment method. Femurs and tibias were separated and both ends of each femur or tibia were cut.
Pooled cells from different donors were cultured in T-75 cell culture flask, with a cell concentration of 1 × 10 5 /mL, using complete media composed of DMEM-F12 (Gibco, USA), supplemented with fetal bovine serum (FBS) (10%, v/v, Solarbio Co., Beijing, China), penicillin: streptomycin (100 μL/100 mL) (Solarbio Co., Beijing, China). Cells were incubated under standard cell culture conditions with 5% CO 2 , at 37°C and 95% relative humidity. The medium was changed every three days, and BMSCs were passaged when 80%-90% confluency was reached. BMSC identity was confirmed on the basis of morphological criteria, plastic adherence, and specific surface antigen expression: CD29(+), CD90(+), CD34(−), CD45(−).
| Experimental equipment
The LIPUS exposure consisted of a power supply, a function generator, an amplification module, and a transducer. The central frequency of transducer is 1 MHz, whose outside diameter is 10 mm. The distance from the surface of the transducer to the cell
bone marrow mesenchymal stem cells, low-intensity pulsed ultrasound, spinal cord injury, stem cell transplantation layer was 5 mm, which was fixed and kept constant throughout all experiments. The schematic representation of LIPUS exposure process is shown in Figure 1A . According to various voltage and frequency, the acoustic intensity, which was used to stimulate BMSCs, was measured by Hangzhou Applied Acoustics Research Institute.
| LIPUS stimulation
BMSCs were seeded at a density of 1 × 10 5 per well in 24-well plates 3 days before LIPUS experiments to permit cell attachment to the plates. Prior to ultrasound exposure, the medium was rinsed with phosphate-buffered saline (PBS) (Solarbio Co., Beijing, China).
LIPUS was used to stimulate the BMSCs after adding 1 mL of medium to each well. To determine the optimal LIPUS intensity, cells were exposed by pulsed ultrasound with different intensities (10, 30, 50 , 70 mW/cm 2 , 3 min/d, 3 days). The control group underwent the same submersion without ultrasound stimulation. After LIPUS stimulation for predetermined parameters, samples were rinsed again using PBS.
| Determination of optimal LIPUS parameters
After LIPUS stimulation, the cells were lifted with 0.25% trypsin-EDTA solution (Solarbio Co., Beijing, China). Cells were seeded at a density of 1 × 10 4 per well (100 μL) in 96-well plates, while a blank well was kept for medium without cells in every plate. Cell proliferation was quantified 24 hours later by cell counting kit-8 (CCK-8) following the manufacturer's protocol (BestBio, China). 10 μL CCK-8 solution was added in each well, and the complete media was incubated for 2 hours before determination. The final optical density (OD) was measured at a wavelength of 450 nm to estimate cell proliferation in the different groups.
The experiment was repeated eight independent times. BMSCs stimulated by LIPUS with the best parameter were set as the experimental group, to be compared with the control group in other tests.
| Flowcytometric analysis of cultureexpanded BMSCs
To characterize the cell markers of culture-expanded cells after LIPUS stimulation, monolayer adherent cells (Passage 3) were Flowcytometric analyses were performed using PAS flowcytometry (Partec GmbH, Germany). 
| Trophic factor examination
| Population doubling time (PDT) of BMSCs
The populations of BMSCs in each group from passage 3 were trypsinized from the culture disks before plating into the 24-well plates at a density of 3 × 10 
| Cell apoptosis
Apoptosis was evaluated with the TUNEL method, according to the manufacturer's protocol (Roche). Air-dried BMSCs were fixed with freshly prepared paraformaldehyde for 1 hour at room temperature.
The cells were rinsed with PBS before and after they were incubated with Triton X-100 on ice for 2 minutes. Then, the BMSCs with their peripheral area were dried again. The TUNEL reaction mixture was prepared immediately (Enzyme solution: Label Solution = 1:9) and then added on the cells (50 μL each well). Then, BMSCs samples were incubated in a humidified atmosphere in the dark for 60 minutes at 37°C.
PBS was used to rinse the slide. Label Solution was used alone for negative controls, while fixed and permeabilized cells were incubated with micrococcal nuclease for 10 minutes at room temperature for positive controls. Photomicrographs of 20 random fields per experimental condition were taken (Olympus AX70) at 40× magnification.
| Transwell migration assay
Cell invasion ability was assessed using a 24-well transwell chamber ( 
| Statistical analysis
The data collected in the present study are presented as mean standard deviation (mean SD) and analyzed by one-way repeated measures ANOVA, followed by post hoc test for least significant difference (LSD) to determine differences between two groups.
Statistical significance was defined as P < 0.05. with the tail wagged involuntarily, which was in accordance with the standards of the SCI model. After the operation, the rats were put in incubation chambers with appropriate humidity and temperature until they awoke. After that, the rats were transferred to individual cages and bladder evacuation was implemented every day, until the rats gained autourination function.
| Establishment of SCI model
| Cell transplantation
One week after the day of injury, all rats with SCI were assessed for locomotion and excluded if one hindlimb joint could move before transplantation. Rats were then anesthetized and immobilized in a stereotaxic frame. All surgical procedures were performed under sterile conditions. The injured cords were exposed, and fluid from the cavity was aspirated before cell grafting. PBS (10 μL) or a total of 5 × 10 5 cells (10 μL) was injected into the epicenter of the SCI (with a needle at an angle of 45° rostral and caudal to the injury site and at an angle of 90° at the center of the injury site). Following surgery, the rats received intensive care for 2 weeks until spontaneous bladder function was recovered, which was indicated by overfilling of the bladder. 
| Behavioral observation
| HE staining
Rats were sacrificed and perfused with normal saline solution 
| Increased cell proliferation of BMSCs after LIPUS stimulation
To determine the best LIPUS intensity, a CCK-8 assay was used to de- 
| Effect of LIPUS stimulation upon BMSCs
After BMSCs were stimulated by LIPUS, apoptosis of BMSCs in control group and LIPUS group was examined using TUNEL staining. In each group, four fixed sites (up, down, left, and right) were photographed and used for calculating the cell apoptosis ( Figure 2C and D). We found that LIPUS stimulation did not significantly increase the apoptosis of BMSCs ( Figure 2E ; P > 0.05).
| Enhanced expression of neurotrophic factors after stimulation with LIPUS in vitro
To examine whether LIPUS stimulation can enhance the ability of BMSCs (P3 cell culture) to produce more neurotrophic factors in vitro, the expression level of BDNF and NGF in both cytosol (by Western blot analysis) and supernatant (by ELISA analysis) of BMSCs before and after LIPUS stimulation were examined. We showed that the expression of BDNF and NGF was significantly upregulated in cytosol ( Figure 3A -C) and supernatant ( Figure 3D and E), which may be associated with increased cell viability of
BMSCs following LIPUS stimulation.
| Migration and differentiation after LIPUS stimulation
To investigate the migration ability after LIPUS stimulation, transwell assay was employed, the results demonstrated that the migration of BMSCs ( Figure 4B ) was significantly upregulated compared with BMSCs without treatment ( Figure 4A) . Notably, as shown in Figure 4C , the number of cells treated with LIPUS that migrated was almost 2-fold more than control (P < 0.0001),
suggesting LIPUS stimulation can effectively enhance the migration ability of BMSCs in vitro. We also examined differentiation of BMSCs following LIPUS stimulation using Western blot. The expression of NSE and GFAP was used to determine neuronal and gliosis differentiation, respectively ( Figure 4D ). The results suggested that LIPUS stimulation inhibited gliosis differentiation (P < 0.05) ( Figure 4E ) but did not promote neuronal differentiation (n = 0.057) ( Figure 4F ).
| Evaluation of locomotor function
The 
| Morphology of the lesion site revealed by HE staining
Rats in each group were sacrificed and perfused after 8 weeks of SCI. Tissue in the Sham group remained intact without mass and Injury group (P < 0.0001) ( Figure 5I ). This result indicated that LIPUS-BMSCs transplantation can promote better recovery after SCI.
F I G U R E 3 A-C, Western blotting results show expression of BDNF (B) and NGF (C) in control group and LIPUS stimulation group. Graphs indicate relative band intensities compared with that of β-actin (A) (n = 3 for each group). The intensity of BDNF (B) and NGF (C) bands in the LIPUS
| Transplantation of LIPUS-BMSCs promoted axon regeneration and reduced reactive gliosis
Previous studies have demonstrated that BMSCs with LIPUS stimulation obtained significantly higher viability, the rate of apoptosis the lesion site; however, the difference was not significant after calculation ( Figure 6B ). This indicated that LIPUS-BMSCs transplantation may not be more effective compared with BMSCs transplantation with regard to promoting nerve fiber growth. However, this could be the result of the inhibitory microenvironment in the injury site after SCI.
GFAP was employed as a marker of astrocyte activation ( Figure 6C ).
We examined tissue sections at the epicenter 56 days after SCI, and the level of immunofluorescence was quantitated using ImageJ software. Overall, there was a 2-3-fold increase in GFAP immunoreactivity in Injury group as compared to tissue from sham-injured mice.
GFAP immunoreactivity in BMSCs group and LIPUS-BMSCs group
was significantly lower than the Injury group (*P < 0.05), and GFAP immunoreactivity in LIPUS-BMSCs group was significantly lower than that of BMSCs group (*P < 0.05) ( Figure 6D ). The result indicates that both BMSCs transplantation and LIPUS-BMSCs transplantation can provide help to reduce the reactive gliosis. Furthermore, LIPUSBMSCs transplantation can further alleviate the astroglial activation process during the repair after SCI.
| Neurotrophic factors and receptor expression after transplantation treatment
Rats in each group were sacrificed on day 56 after SCI, and tissue biopsies around lesion epicenter (T10 level) were obtained for ELISA analysis to examine the expression of BDNF and NGF. The results of the ELISA analysis ( Figure 6E and F) for the The results demonstrated that rats in the LIPUS-BMSCs transplantation group have the best hindlimb functional recovery among all the groups. From the time point of 49 days, the curve in the four groups gradually plateaued. BBB locomotor functional score is given as the mean for all four groups and error bars represent the SD. Analysis was performed using two-way ANOVA with Bonferroni posttests, *P < 0.05, **P < 0.01, ***P < 0.001 compared with Injury group. #*P < 0.05, #**P < 0.01, #***P < 0.001, compared with BMSCs transplantation group 
| D ISCUSS I ON
Effective treatment strategies for SCI with satisfactory improvement in locomotor and neurological function have always been the focus of the basic research. 24 Stem cell transplantation is a potential Therefore, the effect of LIPUS on microenvironment following SCI may inhibit the inflammatory response by inhibiting the NF-κB signaling pathway and promote the repair of SCI. 54, 55 Meanwhile, remyelination is a crucial step for functional restoration after SCI, growth factors, and neurotrophic factors have been used to boost the endogenous progenitor response to facilitate oligodendrocytes survival and remyelination process. 56 According to our present research, BMSCs are mainly served as a neurotrophic factor-secreting stem cell, and BMSCs stimulated with LIPUS obtained the ability to secrete more neurotrophic factors, which may be beneficial for the remyelination process of oligodendrocyte progenitor cells and oligodendrocytes.
Additionally, we will also be probing the expression of inflamma- 
| CON CLUS ION
In conclusion, LIPUS can improve BMSCs viability and neurotrophic factor expression in vitro. Similarly, transplantation of LIPUS-BMSCs could promote better functional recovery than BMSCs transplantation without stimulation, indicating a translational application for the treatment of SCI.
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